Zhenli Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhenli Guo has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Lizhu Chen
Department of Neurology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, No. 11 Lingjiaohu Road, Wuhan, Hubei 430015, China
2 shared publicationsQian Tan
Department of Neurology, Hubei Hospital of Integrated Traditional Chinese and Western Medicine, Wuhan, China
2 shared publications- Chao Han
Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, China
1 shared publication Danfang Yu
Department of Neurology Hubei Provincial Hospital of Integrated Chinese and Western Medicine Wuhan China
1 shared publication- Guiqin Chen
Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, China
1 shared publication Hui Wang
Department of Neurology Hubei Provincial Hospital of Integrated Chinese and Western Medicine Wuhan China
1 shared publication
Latest Publications
- 17 February 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 343, 119508
Jiajian Shuyu pills effectively ameliorate cognitive impairment via regulating the inflammation of microglia in an Alzheimer's disease mouse model
- 17 February 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 343, 119508
Jiajian Shuyu pills effectively ameliorate cognitive impairment via regulating the inflammation of microglia in an Alzheimer's disease mouse model
- 30 May 2024
- Published by Springer Nature in Molecular & Cellular Toxicology
- Vol. 21 (1) , 303-313
Dietary flavonoids protect human brain microvascular endothelial cell from oxidative stress-induced dysfunction
- 30 May 2024
- Published by Springer Nature in Molecular & Cellular Toxicology
- Vol. 21 (1) , 303-313
Dietary flavonoids protect human brain microvascular endothelial cell from oxidative stress-induced dysfunction
- Open Access
- 27 August 2022
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 10 (5) , e01001
Biphasic effects of statins on neuron cell functions under oxygen–glucose deprivation and normal culturing conditions via different mechanisms
While there is a growing interest in the use of statins, HMG‐CoA reductase inhibitors, to treat neurodegenerative diseases, statins are associated with conflicting effects within the central nervous system (CNS) without clear evidence of the underlying mechanisms. This study systematically investigated effects of four statins (atorvastatin, pitavastatin, cerivastatin, and lovastatin) on neuronal cells under pathological condition using an in vitro model depicting ischemic injury, as well as tested under physiological condition. All four statins at micromolar concentrations display toxic effects on neuron cells under physiological condition. Atorvastatin and cerivastatin but not pitavastatin or lovastatin at nanomolar concentrations display protective effects on neuron cells under ischemic injury condition, via decreased ischemic injury‐induced oxidative stress, oxidative damage, and inflammation. Mechanistically, atorvastatin, pitavastatin, and lovastatin induces neuron cell apoptosis via prenylation‐independent manner. Other mechanisms are involved in the pro‐apoptotic effect of cerivastatin. Prenylation is not involved in the protective effects of statins under ischemic injury condition. Our work provides better understanding on the multiple differential effects of statins on neuron cells under physiological condition and ischemic injury, and elucidate their underlying mechanisms, which may be of relevance to the influence of statins in CNS.
- 27 August 2022
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 10 (5) , e01001
Open AccessBiphasic effects of statins on neuron cell functions under oxygen–glucose deprivation and normal culturing conditions via different mechanisms
While there is a growing interest in the use of statins, HMG‐CoA reductase inhibitors, to treat neurodegenerative diseases, statins are associated with conflicting effects within the central nervous system (CNS) without clear evidence of the underlying mechanisms. This study systematically investigated effects of four statins (atorvastatin, pitavastatin, cerivastatin, and lovastatin) on neuronal cells under pathological condition using an in vitro model depicting ischemic injury, as well as tested under physiological condition. All four statins at micromolar concentrations display toxic effects on neuron cells under physiological condition. Atorvastatin and cerivastatin but not pitavastatin or lovastatin at nanomolar concentrations display protective effects on neuron cells under ischemic injury condition, via decreased ischemic injury‐induced oxidative stress, oxidative damage, and inflammation. Mechanistically, atorvastatin, pitavastatin, and lovastatin induces neuron cell apoptosis via prenylation‐independent manner. Other mechanisms are involved in the pro‐apoptotic effect of cerivastatin. Prenylation is not involved in the protective effects of statins under ischemic injury condition. Our work provides better understanding on the multiple differential effects of statins on neuron cells under physiological condition and ischemic injury, and elucidate their underlying mechanisms, which may be of relevance to the influence of statins in CNS.
- 13 May 2022
- Published by Elsevier in Journal of Affective Disorders
- Vol. 312, 331-336
Association of mental health with clinical outcomes in hospitalized patients with moderate COVID-19
- 13 May 2022
- Published by Elsevier in Journal of Affective Disorders
- Vol. 312, 331-336
Association of mental health with clinical outcomes in hospitalized patients with moderate COVID-19
- 1 December 2015
- Published by Elsevier in Neuropharmacology
- Vol. 99, 448-458
Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents
- 1 December 2015
- Published by Elsevier in Neuropharmacology
- Vol. 99, 448-458
Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents